These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12793598)

  • 1. Role of statin pleiotropism in acute coronary syndromes and stroke.
    Liao JK
    Int J Clin Pract Suppl; 2003 Mar; (134):51-7. PubMed ID: 12793598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current questions regarding the use of statins in patients with coronary heart disease.
    Rallidis LS; Lekakis J; Kremastinos DT
    Int J Cardiol; 2007 Nov; 122(3):188-94. PubMed ID: 17399827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of statins on stroke and cardiovascular incidence in randomized, placebo-controlled trials with clinical endpoints].
    Márk L; Katona A
    Orv Hetil; 2000 Jul; 141(27):1501-5. PubMed ID: 10943107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
    Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
    J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins and stroke].
    Chudzik W; Kaczorowska B; Chmielewski H; Przybyła M; Gałka M
    Pol Merkur Lekarski; 2005 Oct; 19(112):591-5. PubMed ID: 16379334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
    Wiviott SD; Cannon CP
    Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving greater reductions in cardiovascular risk: lessons from statin therapy on risk measures and risk reduction.
    Ballantyne CM
    Am Heart J; 2004 Jul; 148(1 Suppl):S3-8. PubMed ID: 15211326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of statins in prevention of ischemic stroke].
    Pankiewicz J; Dembińska-Kieć A; Słowik A; Rudzińska M; Szczudlik A
    Przegl Lek; 2000; 57(7-8):406-10. PubMed ID: 11109315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U; Gathof BS
    Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pleiotropic effects of statins].
    Wolfovitz E
    Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
    Robinson JG; Smith B; Maheshwari N; Schrott H
    J Am Coll Cardiol; 2005 Nov; 46(10):1855-62. PubMed ID: 16286171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the laboratory: clinical implications for statin pleiotropy.
    Halcox JP; Deanfield JE
    Circulation; 2004 Jun; 109(21 Suppl 1):II42-8. PubMed ID: 15173062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects.
    Miida T; Takahashi A; Ikeuchi T
    Pharmacol Ther; 2007 Feb; 113(2):378-93. PubMed ID: 17113151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic effects and cholesterol-lowering therapy.
    Shaw SM; Fildes JE; Yonan N; Williams SG
    Cardiology; 2009; 112(1):4-12. PubMed ID: 18577880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
    McKenney JM
    Am J Cardiol; 2005 Aug; 96(4A):60E-66E. PubMed ID: 16098846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin pleiotropy: fact or fiction?
    Futterman LG; Lemberg L
    Am J Crit Care; 2004 May; 13(3):244-9. PubMed ID: 15149060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.